Worth the Wait
Neoadjuvant therapy—using treatments to shrink a tumor or treat unseen metastases before surgery—can improve outcomes for some patients.
Progress Against Cancer
Neoadjuvant therapy—using treatments to shrink a tumor or treat unseen metastases before surgery—can improve outcomes for some patients.
Advances in precision medicine and immunotherapy have led to better treatments for many patients with advanced lung cancer.
A therapeutic vaccine targeting advanced cervical cancer.
Fear of discrimination may lead to lower screening rates.
The Clinical Treatment Act aims to include more Medicaid recipients.
Study finds acupuncture can help reduce cancer-related pain.
Compromises between length and quality of life should be informed by thorough research.
Paying attention to the social determinants of health will promote greater equity in cancer outcomes for all.
September is Childhood Cancer Awareness Month. Childhood cancer is relatively rare, but it is a devastating diagnosis that can ravage a family and create lifelong health challenges. In the United States, approximately 15,590 children...
Investigators present results from a phase III clinical trial of Trodelvy as a treatment for metastatic triple-negative breast cancer, and more news of the week from Cancer Today.
AACR Fellow Lewis C. Cantley, PhD, leads a national effort targeting triple-negative breast cancer and ovarian cancer with a novel drug combination.
Learn More